Deciphera Pharmaceuticals (DCPH) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts DCPH Hot Sheet
Join SI Premium – FREE
Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($1.21), $0.06 worse than the analyst estimate of ($1.15). Revenue for the quarter came in at $22 million versus the consensus estimate of $22 million.
For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Owlet (OWLT) Tops Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
